Using an antibacterial matrix device for breast reconstruction
Official title: Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction With Infection Outcomes Assessment (ARIA)
Run by Melodi Health, Inc. · NCT06027996 · Data updated 2026-11-12
This study is testing whether an antibacterial device can help improve recovery and reduce complications for patients getting breast reconstruction after a mastectomy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years and up |
| Sex | Women only |
| Enrollment | 702 (estimated) |
| Sponsor | Melodi Health, Inc. Industry-sponsored |
| Locations | 10 sites (Palo Alto, California and 9 other locations) |
| Status | Recruiting |
| Started | August 9, 2024 |
| Main results expected | December 2027 |
| Study ends | June 2028 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT06027996 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are females aged 22 or older scheduled for unilateral or bilateral mastectomy with immediate reconstruction.
✕Probably not a fit
Patients with a history of neoadjuvant radiotherapy or those with active infections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the safety and effectiveness of an absorbable antibacterial matrix device in patients undergoing two-stage prepectoral alloplastic breast reconstruction following mastectomy. It is a prospective, multicenter, randomized, controlled trial designed to compare outcomes between those receiving the matrix device and those who do not. The study aims to assess how this device may improve surgical outcomes and reduce complications in breast reconstruction procedures.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and reduce infection rates in patients undergoing breast reconstruction.
How similar studies have gone: Other studies have shown promising results with similar antibacterial approaches in surgical settings, suggesting potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female. * Age 22 or older at the time of enrollment. * Is scheduled to undergo unilateral or bilateral mastectomy (including prophylactic) with immediate two-stage post-mastectomy alloplastic prepectoral breast reconstruction. * Is able to and willing to comply with the study requirements and providing informed consent. Exclusion Criteria: * Has prior history of neoadjuvant radiotherapy. * Has had prior history of failed tissue expansion or breast implantation at the intended reconstruction site. * Has an active abscess or infection requiring antibiotics anywhere in their body within 30 days. * Has a Body Mass Index (BMI) \< 14 or \> 40. * Is pregnant or is nursing; or plans to become pregnant during the course of the study. * Has any connective tissue/autoimmune disorder or rheumatoid disease. * Has known allergies to study device materials. * Is participating in another interventional research study that may interfere with study endpoints. * Has limited life expectancy or co-morbid conditions, social/psychological problems, or cognitive impairments that precludes participation. * Has a medical condition or is taking medications that would result in elevated risk and/or affect the validity of the study. * Intraoperative assessment demonstrates unfavorable conditions (i.e., poor mastectomy skin flap thickness or viability) for immediate, two-stage post-mastectomy alloplastic prepectoral reconstruction in any breast.
Where it's running
-
Stanford University
Palo Alto, California, United States Recruiting -
University of Michigan Health
Ann Arbor, Michigan, United States Recruiting -
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Northwell Health
Staten Island, New York, United States Recruiting -
The Ohio State University
Columbus, Ohio, United States Recruiting -
Upmc
Pittsburgh, Pennsylvania, United States Recruiting
Show 4 more locations
-
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
Monument Health
Rapid City, South Dakota, United States Recruiting -
MD Anderson Cancer Center
Houston, Texas, United States Recruiting -
University of Utah
Salt Lake City, Utah, United States Recruiting
Study contacts
- Study coordinator: Michele Hilmer
- Email: michele.hilmer@melodihealth.com
- Phone: 210-279-0194
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ESP Blocks to Help Pain After Breast Reconstruction with Autologous Flaps
This study tests whether erector spinae plane blocks can improve pain control after autologous free flap breast reconstruction in adults.
-
EndoBreast: Feasibility and outcomes of nipple-sparing endoscopic mastectomy with immediate reconstruction
This observational study tests whether endoscopic nipple-sparing mastectomy with immediate reconstruction is feasible and acceptable for women at risk or with breast cancer.
-
Access My Breast Cancer Care App
A breast cancer care app is being tested to see if it helps patients navigate care, feel more satisfied, and reduce in-person visits.
-
Breast implant study to see how Luna implants perform after surgery
This study tests whether Eurosilicone Luna breast implants stay intact and keep their shape over 10 years in women aged 18–65 undergoing cosmetic or reconstructive breast surgery.
-
Autologous Fat Grafting vs DIEP flap for reconstructed breast after radiation
This study tests whether autologous fat transfer can provide similar satisfaction and safety to the DIEP flap procedure for women needing breast reconstruction after mastectomy and radiation.
-
Prehabilitation with physiotherapy and mechanical stimulation before LD flap breast reconstruction
This study tests whether prehabilitation with physiotherapy and mechanostimulation improves shoulder pain and mobility for women undergoing breast reconstruction with a latissimus dorsi flap.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.